Cardiology
Diabetics have fewer cardiovascular events with metformin than with glipizide
JANUARY 01, 2013NEW YORK (Reuters Health) - Compared with glipizide, long-term therapy with metformin leads to a reduction in major cardiovascular events in patients with type 2 diabetes, according to Chinese and US researchers.
JANUARY 01, 2013NEW YORK (Reuters Health) - Compared with glipizide, long-term therapy with metformin leads to a reduction in major cardiovascular events in patients with type 2 diabetes, according to Chinese and US researchers.
